So they've done it again, figured out a way to divide us to try to keep Leronlimab from approval until big pharma makes the money by either taking it or slow walking it to death.

Remember how we were going to have a trial with Remdesivir; that sure wasn't going happen no matter who was at the helm. It started from the beginning.

I have Leronlimab at about 84% effective if it's given as a prophylactic treatment for Long Hauler's and for severe/critical. Not for everyone, but for most. The spin offs would be amazing. Will be a very, very tough approval for anyone.